Back to Journals » OncoTargets and Therapy » Volume 11

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

Total article views   HTML views PDF downloads Totals
9,250 Dovepress* 7,774+ 1,472 9,246
PubMed Central* 1,476 387 1,863
Totals 9,250 1,859 11,109
*Since 22 December 2017
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar